Analyzing the prognostic role of cancer-associated myofibroblasts, considerable evidence has shown that the expression of their marker, α-SMA, was significantly higher in OSCC, particularly in moderately differentiated carcinomas and in metastatic lesions [50]. The gene discussed is ACTA1; the disease is cancer.